scholarly journals Silk fibroin nanoparticles constitute a vector for controlled release of resveratrol in an experimental model of inflammatory bowel disease in rats

2014 ◽  
pp. 4507 ◽  
Author(s):  
Julio Galvez ◽  
Alba Rodriguez-Nogales ◽  
Victor Ortiz ◽  
Francesca Algieri ◽  
Pedro Zorrilla ◽  
...  
2014 ◽  
Vol 44 ◽  
pp. 166-174 ◽  
Author(s):  
Jing Qu ◽  
Yu Liu ◽  
Yanni Yu ◽  
Jing Li ◽  
Jingwan Luo ◽  
...  

2019 ◽  
Vol 9 (4) ◽  
pp. 601-608 ◽  
Author(s):  
Hamid Rahmani ◽  
Ali Fattahi ◽  
Komail Sadrjavadi ◽  
Salar Khaledian ◽  
Yalda Shokoohinia

Purpose: The aim of this study is to prepare 5-fluorouracil (5-FU) loaded silk fibroin nanoparticles(SFNPs) and to achieve a controlled release delivery system with the high loading capacity. Methods: SFNPs with 1:1, 1:3, and 1:10 ratios of 5-FU to silk fibroin were prepared. SFNPswere characterized by Fourier-transform infrared spectroscopy (FT-IR), X-ray diffraction (XRD)analysis, Scanning electron microscope (SEM), and Transmission electron microscope (TEM).Loading efficiency, in vitro release, and cell viability were studied for optimal SFNPs. Results: The ratio of 1:1 was optimal formulation with the size and polydispersity index (PDI)of 221.03 nm and 0.093 before freeze drying, and 286.7 nm and 0.154 after freeze dryingby lactose, respectively. The loading efficiency and loading content of this ratio were 52.32%and 34.35%, respectively. FT-IR and XRD analysis indicated the conformational change (fromrandom coil to β-sheet) in the structure of nanoparticles by increasing amount of the drug, whichcaused the smaller size, the higher loading efficiency, and the slower release pattern. The drugloadednanoparticles reached to the half maximal inhibitory concentration (IC50) that werecomparable with free drug on MCF7 (human breast cancer) cell line. Conclusion: This study was planned to achieve a promising controlled release drug deliverysystem for carrying 5-FU, as a potent anticancer drug. SFNPs were found proper candidates fordelivery of a hydrophilic drug such as 5-FU.


Author(s):  
Patricia Diez-Echave ◽  
Antonio Jesús Ruiz-Malagón ◽  
José Alberto Molina-Tijeras ◽  
Laura Hidalgo-García ◽  
Teresa Vezza ◽  
...  

Drug Delivery ◽  
2021 ◽  
Vol 28 (1) ◽  
pp. 1626-1636
Author(s):  
Afrasim Moin ◽  
Shahid Ud Din Wani ◽  
Riyaz Ali Osmani ◽  
Amr S. Abu Lila ◽  
El-Sayed Khafagy ◽  
...  

2021 ◽  
Author(s):  
Christian Hundhausen ◽  
Rebekka Schneckmann ◽  
Yanina Ostendorf ◽  
Jacqueline Rimpler ◽  
Anette von Glinski ◽  
...  

2017 ◽  
Vol 9 (37) ◽  
pp. 31600-31611 ◽  
Author(s):  
Fatemeh Mottaghitalab ◽  
Melika Kiani ◽  
Mehdi Farokhi ◽  
Subhas C. Kundu ◽  
Rui L. Reis ◽  
...  

2011 ◽  
Vol 59 (18) ◽  
pp. 10298-10302 ◽  
Author(s):  
Lin Zhu ◽  
Ren-Ping Hu ◽  
Hai-Yan Wang ◽  
Yuan-Jing Wang ◽  
Yu-Qing Zhang

Sign in / Sign up

Export Citation Format

Share Document